Diversified Trust Co. Lowers Stock Position in Ventas, Inc. $VTR

Key Points

• Diversified Trust Co. cut its Ventas stake by 88.9% in Q4, selling 33,835 shares and leaving 4,234 shares valued at about $328,000, while institutional investors own roughly 94.18% of the stock.
• Ventas missed Q4 estimates, reporting $0.15 EPS versus $0.89 expected and revenue below forecasts, though it issued FY2026 guidance of $3.78–$3.88 and analysts hold a "Moderate Buy" consensus with a $90.47 target.
• Dividend raised and notable insider selling: Ventas increased its quarterly dividend to $0.52 (annualized $2.08, ~2.5% yield), even as executives sold large blocks (86,106 shares worth ~$6.93M sold in the last 90 days).

Diversified Trust Co. decreased its holdings in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 88.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,234 shares of the real estate investment trust's stock after selling 33,835 shares during the period. Diversified Trust Co.'s holdings in Ventas were worth $328,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Cloud Capital Management LLC purchased a new stake in shares of Ventas in the third quarter valued at approximately $25,000. GoalVest Advisory LLC purchased a new position in Ventas in the fourth quarter worth $26,000. Wiser Advisor Group LLC purchased a new position in Ventas in the third quarter worth $27,000. True Wealth Design LLC lifted its holdings in Ventas by 1,557.7% in the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust's stock valued at $30,000 after acquiring an additional 405 shares during the period. Finally, ORG Partners LLC lifted its holdings in Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock valued at $32,000 after acquiring an additional 197 shares during the period. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Trading Down 0.8%

Shares of VTR stock opened at $82.00 on Friday. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $88.36. The stock has a market cap of $38.95 billion, a P/E ratio of 151.86, a P/E/G ratio of 2.02 and a beta of 0.73. The business has a fifty day simple moving average of $83.04 and a 200-day simple moving average of $77.53. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analysts' expectations of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.Ventas's quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, analysts forecast that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. This is a boost from Ventas's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas's payout ratio is currently 385.19%.

Insider Activity

In other news, CFO Robert F. Probst sold 29,930 shares of the firm's stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares of the company's stock, valued at $10,694,026.50. This trade represents a 17.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares of the company's stock, valued at $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 86,106 shares of company stock worth $6,931,397 over the last ninety days. 0.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

VTR has been the topic of a number of recent analyst reports. Argus set a $88.00 price target on shares of Ventas in a research note on Tuesday, February 10th. KeyCorp raised their price objective on shares of Ventas from $85.00 to $90.00 and gave the company an "overweight" rating in a research note on Tuesday, February 10th. Citigroup boosted their price objective on shares of Ventas from $88.00 to $96.00 and gave the stock a "buy" rating in a report on Wednesday, February 11th. Scotiabank upped their target price on shares of Ventas from $80.00 to $93.00 and gave the stock a "sector perform" rating in a research report on Monday, March 2nd. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $100.00 target price on shares of Ventas in a report on Monday, February 9th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Ventas currently has an average rating of "Moderate Buy" and a consensus target price of $90.47.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.